يعرض 1 - 10 نتائج من 20 نتيجة بحث عن '"Tuberculostatic agent"', وقت الاستعلام: 0.98s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2

    المصدر: PLoS ONE, Vol 13, Iss 12, p e0206658 (2018)
    PLoS ONE

    مصطلحات موضوعية: Male, antibiotic resistance, retrospective study, lack of drug effect, Geographical locations, 0302 clinical medicine, drug resistant tuberculosis, middle aged, Peru, Child, adult, Isoniazid, cohort analysis, Actinobacteria, aged, Child, Preschool, monotherapy, Medicine, Drug Therapy, Combination, Rifampin, Ethambutol, medicine.medical_specialty, Tuberculosis, Science, 030106 microbiology, Microbiology, Article, 03 medical and health sciences, Drug Therapy, death, Humans, cross-sectional study, purl.org/pe-repo/ocde/ford#3.01.05 [https], human, Retrospective Studies, Pharmacology, Drug Screening, levofloxacin, treatment duration, Bacteria, Organisms, Infant, Biology and Life Sciences, Tropical Diseases, medicine.disease, major clinical study, antibiotic sensitivity, Regimen, Cross-Sectional Studies, People and places, Bacterial Diseases, 0301 basic medicine, Time Factors, ethambutol, Levofloxacin, Drug resistance, rifampicin, Tuberculosis, Multidrug-Resistant, Medicine and Health Sciences, 030212 general & internal medicine, child, Multidisciplinary, Pharmaceutics, Multi-Drug-Resistant Tuberculosis, Multi-drug-resistant tuberculosis, Middle Aged, Infectious Diseases, female, Tuberculosis Diagnosis and Management, young adult, Female, Research Article, medicine.drug, Adult, isoniazid, pyrazinamide, Adolescent, Sex Factors, male, Diagnostic Medicine, Microbial Control, Internal medicine, medicine, follow up, controlled study, infection risk, business.industry, Infant, Newborn, South America, Pyrazinamide, infant, Antibiotic Resistance, adolescent, purl.org/pe-repo/ocde/ford#3.02.07 [https], treatment outcome, tuberculostatic agent, Antimicrobial Resistance, business, Mycobacterium Tuberculosis, Rifampicin

    وصف الملف: application/pdf

  3. 3
  4. 4
  5. 5
    دورية أكاديمية
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10